New PharmAnalyser Platform Brings NHS Pharmacy Data Into One Place
FOR IMMEDIATE RELEASE
Glasgow, United Kingdom — 23 February 2026
PharmAnalyser launches UK-wide analytics platform bringing NHS pharmacy and GP practice datasets into one searchable service
PharmAnalyser (pharmanalyser.co.uk) has launched a new analytics platform that brings together official NHS and related public datasets into a single, searchable service covering NHS pharmacies and GP practices across England and Scotland.
Designed for pharmacy teams, researchers and anyone trying to understand local healthcare activity, the platform turns routinely published datasets into interactive profiles, maps and benchmarking views — helping users find information quickly and compare performance without manually stitching together spreadsheets, dashboards and separate data releases.
“We built PharmAnalyser to make NHS contractor datasets usable in the real world,” said Mohammed, spokesperson for PharmAnalyser. “If you’re trying to understand local service delivery patterns, benchmark performance, or spot changes over time, you shouldn’t need specialist tooling just to find the information and interpret it.”
PharmAnalyser allows users to search for NHS contractors and GP practices by name, postcode, location or identifier, then drill into dedicated profile pages. Those profiles bring together published metrics such as dispensing activity and (where present in the underlying datasets) service measures including Pharmacy First and NMS in England and MCR activity in Scotland. England pharmacy profiles can also include opening hours where available, while GP practice profiles can include prescribing volumes and trends and, where published, information that helps users understand where prescriptions are dispensed.
Alongside individual profiles, PharmAnalyser provides national and regional leaderboards across England and Scotland, including a specific view of distance-selling pharmacies (England only). For England, the platform also publishes an EPS nominations leaderboard updated weekly, including movement over time and “biggest winners and losers”, to help users track shifts in nomination volumes.
For users who want to understand activity at system level, PharmAnalyser includes regional analytics for Integrated Care Boards in England and NHS Health Boards in Scotland. ICB pages can include pharmacy leaderboards, FP57 prescription charge refund data and Prescription Cost Analysis views by BNF hierarchy (where available in the published datasets). Scotland Health Board analytics draw on published open data and can include A&E activity and waiting times, cancer waiting times (31-day and 62-day standards), diagnostics waiting times and activity, immunisation uptake and smoking cessation statistics.
PharmAnalyser also includes pharmacy group and ownership views, providing directories and owner/contractor pages that show pharmacies under a given owner name across England and Scotland, with location and dispensing context. A dedicated Scotland prescription analysis section supports community prescription analysis by dispenser and prescriber location, including GP practices, with medication usage and cost views and BNF/dm+d detail.
In addition to open-data analytics, PharmAnalyser offers account features intended for operational benchmarking. These include side-by-side pharmacy comparison tools and a watchlist for pharmacies and GP practices, alongside an account dashboard. The platform also hosts pharmacy rates pages showing aggregated, community-submitted locum pay benchmarks, with submissions limited to verified professionals.
A subscription tier unlocks additional functionality, including a per-pharmacy Competitor Analysis tool. This subscription-only view includes growth comparisons against local and national averages, nearby trend comparisons, identification of top prescriber GP practices from published data, performance snapshots, and opening hours analysis where available.
PharmAnalyser also publishes an MHRA Alerts section covering medicines recalls, device safety information, field safety notices, patient safety alerts and safety round-ups from the UK Government’s medicines regulator, alongside articles and updates on the PharmAnalyser blog.
Data sources and update approach
Data presented on PharmAnalyser is sourced from official or authoritative public datasets and presented in an accessible format. In England, this includes contractor dispensing datasets from NHS England, community pharmacy payment information from NHS Business Services Authority FOI releases, English Prescribing Data for GP prescribing dispensed in the community, and organisation and practice information from Organisation Data Service. In Scotland, sources include contractor activity datasets and community prescription publications from NHS Scotland, as well as NHS Scotland Open Data used to support Health Board analytics.
Additional sources used where applicable include published registration and inspection information from the General Pharmaceutical Council, safety alerts from the Medicines and Healthcare products Regulatory Agency, and company information from Companies House where the feature is used.
As with the underlying publications, datasets are typically released with a delay of around two to three months after the reporting period. England contractor and prescribing data are usually updated monthly, Scotland contractor and prescription data are usually updated quarterly, and EPS nominations data for England are updated weekly. PharmAnalyser updates as new datasets become available.
Availability
PharmAnalyser is available online at pharmanalyser.co.uk. Use of the platform requires registration; anonymous access is not available, and subscription tiers provide unlimited access and include Competitor Analysis.
Company details
PharmAnalyser is operated by Caledonian Tech LTD (Company Number: SC789615).
Registered Office: 41 Milnpark Street, Glasgow, G41 1BB, United Kingdom.
Press and support contact: support@pharmanalyser.co.uk
